EUVIMEDEUVIMED entdecken
Crossref

L26/P-514 Diagnostic Criteria for Early Embryonic Demise in In-Vitro Fertilisation Pregnancies (DeCiDE)

L. Berg, E. Chronopoulou, S. Nedelcu, S. Koulouraki, T. Oke, A. Hay, U. Jahan, R. Jaspal, N. Wimalaweera, S. Kastora, D. Jurkovic

Human Reproduction · 01.07.2026 · 41 (Supplement_1)

DOI: 10.1093/humrep/deag083.847 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Human Reproduction, online erschienen am 08.07.2026. Verfasst von L. Berg und 10 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Study question Could diagnostic criteria for early embryonic demise (EED) specific to in-vitro fertilisation (IVF) pregnancies be developed, and would this facilitate earlier and more accurate diagnosis? Summary answer Landmarks of early pregnancy development lagging ≥7 days behind expected can be used to make an earlier conclusive ultrasound diagnosis of miscarriage in IVF pregnancies. What is known already Diagnostic criteria for EED were developed amongst spontaneously conceived pregnancies. They include a large safety margin to allow for uncertainty around the date of conception. This often causes delays in reaching a conclusive diagnosis, which could be avoided in IVF pregnancies with known conception dates. There are only two published retrospective studies, which have suggested that the absence of an embryo at 45 or 47 days gestation could be diagnostic for EED after IVF. However, there have been no prospective studies investigating this. Study design, size, duration This was a prospective multicentre cohort study. Consecutive IVF patients attending for ultrasound assessment up to nine weeks gestation were included. All pregnancies with no evidence of embryonic cardiac activity and a discrepancy between observed ultrasound morphology and expected developmental landmarks were followed up until pregnancy outcome was known, with the exception of those diagnosed with EED at their initial visit on the basis of current diagnostic criteria. Participants/materials, setting, methods This study was performed in England and Scotland across four reproductive medicine units, two early pregnancy assessment units and one private fertility clinic between November 2024 and January 2026. Ultrasound data were analysed to identify the minimum discrepancy between observed and expected appearances that conferred a certain diagnosis of EED. To assess the impact on follow up, the proportion of pregnancies meeting these criteria was compared to those which met current diagnostic criteria for EED. Main results and the role of chance Of 1271 pregnancies, there were 1014/1271 (80%) in which pregnancy morphology was consistent with conception dates. 120/1271 (9.4%) were excluded due to multiple pregnancy, pregnancy of unknown location, ectopic pregnancy or incomplete miscarriage. In 137/1271 (11%) pregnancies, there was a discrepancy between observed ultrasound morphology and expected appearances based on IVF dates, which was termed ‘date discrepancy’. In patients with a discrepancy <7 days, there were 10/37 (27.0%) live pregnancies and 27/37 (73%) miscarriages. All patients who completed follow up with date discrepancy ≥7 days had a final diagnosis of EED. A date discrepancy of ≥ 7 days at the initial visit had a sensitivity of 75.7% (95% CI, 66% – 83%), a specificity of 100.0% (95% CI, 69.2% - 100.0%), and a positive predictive value of 100.0% (95% CI, 96% to 100.0%). Using a ≥ 7-day cut-off for diagnosis of EED would reduce the need for follow up from 94% using current criteria to 28%. Limitations, reasons for caution The number of patients with confirmed EED was relatively low and there was a 13.2% attrition rate amongst patients in whom initial ultrasound findings demonstrated a date discrepancy but who did not attend for a follow up scan. Wider implications of the findings Avoiding diagnostic delay would allow patients to avoid the psychological and social impact of diagnostic uncertainty, stop luteal support medications, undergo surgical management of miscarriage and continue fertility treatment without unnecessary delay. Reducing the number of follow up visits would provide a cost saving for healthcare providers and patients. Trial registration number No

Zitieren

APA

Berg, L., Chronopoulou, E., Nedelcu, S., Koulouraki, S., Oke, T., Hay, A., Jahan, U., Jaspal, R., Wimalaweera, N., Kastora, S., & Jurkovic, D. (2026). L26/P-514 Diagnostic Criteria for Early Embryonic Demise in In-Vitro Fertilisation Pregnancies (DeCiDE). Human Reproduction, 41(Supplement_1). https://doi.org/10.1093/humrep/deag083.847

Vancouver

Berg L, Chronopoulou E, Nedelcu S, Koulouraki S, Oke T, Hay A, et al. L26/P-514 Diagnostic Criteria for Early Embryonic Demise in In-Vitro Fertilisation Pregnancies (DeCiDE). Human Reproduction. 2026;41(Supplement_1). doi:10.1093/humrep/deag083.847

BibTeX
@article{Berg2026,
  author = {Berg, L. and Chronopoulou, E. and Nedelcu, S. and Koulouraki, S. and Oke, T. and Hay, A. and Jahan, U. and Jaspal, R. and Wimalaweera, N. and Kastora, S. and Jurkovic, D.},
  title = {L26/P-514 Diagnostic Criteria for Early Embryonic Demise in In-Vitro Fertilisation Pregnancies (DeCiDE)},
  journal = {Human Reproduction},
  year = {2026},
  volume = {41},
  number = {Supplement_1},
  doi = {10.1093/humrep/deag083.847}
}
Kostenlos starten →